Cargando…

Comparison of Two Different Protocols of Methotrexate Therapy in Medical Management of Ectopic Pregnancy

BACKGROUND: Ectopic pregnancy (EP) is one of the most dangerous complications of pregnancy and without prompt diagnosis and treatment, it could become a major cause of maternal morbidity and mortality. OBJECTIVES: In this randomized controlled study, we compared single and double dose of methotrexat...

Descripción completa

Detalles Bibliográficos
Autores principales: Saadati, Najmieh, Najafian, Mahin, Masihi, Sara, Safiary, Sara, Abedi, Parvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706730/
https://www.ncbi.nlm.nih.gov/pubmed/26756008
http://dx.doi.org/10.5812/ircmj.20147
_version_ 1782409212357246976
author Saadati, Najmieh
Najafian, Mahin
Masihi, Sara
Safiary, Sara
Abedi, Parvin
author_facet Saadati, Najmieh
Najafian, Mahin
Masihi, Sara
Safiary, Sara
Abedi, Parvin
author_sort Saadati, Najmieh
collection PubMed
description BACKGROUND: Ectopic pregnancy (EP) is one of the most dangerous complications of pregnancy and without prompt diagnosis and treatment, it could become a major cause of maternal morbidity and mortality. OBJECTIVES: In this randomized controlled study, we compared single and double dose of methotrexate (MTX) therapy in the treatment of ectopic pregnancy. PATIENTS AND METHODS: This study was performed on 76 patients who were admitted to Obstetrics Ward with primary diagnosis of ectopic pregnancy based on their medical history, physical examination, beta subunit (β-HCG) level, and transvaginal ultrasonography. Using random block allocation, the patients were classified in two groups of single dose and double dose administration of MTX. In single dose group, 50 mg/m(2) of MTX was given at day 0 and in double dose group, the patients received two doses of MTX at day 0 and 4. The level of β-HCG was measured at day 0, 4, 7 in both groups. The successful treatment was defined as 15% reduction in β-HCG level between day 4 and 7. The two groups were compared with each other with regard to their need for operation, or extra dose of MTX; duration of hospitalization; and MTX complications. RESULTS: Results showed that the rate of success in double dose method was more than single dose one (79% versus 69%) but the difference was not significant (P = 0.29). Although the need for operation and extra dose of MTX were lower in the double dose group (15.8% vs. 18.8% and 5.26% vs. 13.2%, respectively), these differences were not significant too. Duration of hospitalization was significantly lower in double dose compared to the single dose (11.55 d vs. 14.76 d, P < 0.001). CONCLUSIONS: Single dose therapy of MTX has sufficient power and efficacy in the treatment of ectopic pregnancy, however in patients with higher serum level of β-HCG, the successful treatment increases by using double dose method. Using double dose also could decrease the necessity of operation, re-administration of MTX, and duration of hospitalization.
format Online
Article
Text
id pubmed-4706730
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-47067302016-01-11 Comparison of Two Different Protocols of Methotrexate Therapy in Medical Management of Ectopic Pregnancy Saadati, Najmieh Najafian, Mahin Masihi, Sara Safiary, Sara Abedi, Parvin Iran Red Crescent Med J Research Article BACKGROUND: Ectopic pregnancy (EP) is one of the most dangerous complications of pregnancy and without prompt diagnosis and treatment, it could become a major cause of maternal morbidity and mortality. OBJECTIVES: In this randomized controlled study, we compared single and double dose of methotrexate (MTX) therapy in the treatment of ectopic pregnancy. PATIENTS AND METHODS: This study was performed on 76 patients who were admitted to Obstetrics Ward with primary diagnosis of ectopic pregnancy based on their medical history, physical examination, beta subunit (β-HCG) level, and transvaginal ultrasonography. Using random block allocation, the patients were classified in two groups of single dose and double dose administration of MTX. In single dose group, 50 mg/m(2) of MTX was given at day 0 and in double dose group, the patients received two doses of MTX at day 0 and 4. The level of β-HCG was measured at day 0, 4, 7 in both groups. The successful treatment was defined as 15% reduction in β-HCG level between day 4 and 7. The two groups were compared with each other with regard to their need for operation, or extra dose of MTX; duration of hospitalization; and MTX complications. RESULTS: Results showed that the rate of success in double dose method was more than single dose one (79% versus 69%) but the difference was not significant (P = 0.29). Although the need for operation and extra dose of MTX were lower in the double dose group (15.8% vs. 18.8% and 5.26% vs. 13.2%, respectively), these differences were not significant too. Duration of hospitalization was significantly lower in double dose compared to the single dose (11.55 d vs. 14.76 d, P < 0.001). CONCLUSIONS: Single dose therapy of MTX has sufficient power and efficacy in the treatment of ectopic pregnancy, however in patients with higher serum level of β-HCG, the successful treatment increases by using double dose method. Using double dose also could decrease the necessity of operation, re-administration of MTX, and duration of hospitalization. Kowsar 2015-12-13 /pmc/articles/PMC4706730/ /pubmed/26756008 http://dx.doi.org/10.5812/ircmj.20147 Text en Copyright © 2015, Iranian Red Crescent Medical Journal. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Saadati, Najmieh
Najafian, Mahin
Masihi, Sara
Safiary, Sara
Abedi, Parvin
Comparison of Two Different Protocols of Methotrexate Therapy in Medical Management of Ectopic Pregnancy
title Comparison of Two Different Protocols of Methotrexate Therapy in Medical Management of Ectopic Pregnancy
title_full Comparison of Two Different Protocols of Methotrexate Therapy in Medical Management of Ectopic Pregnancy
title_fullStr Comparison of Two Different Protocols of Methotrexate Therapy in Medical Management of Ectopic Pregnancy
title_full_unstemmed Comparison of Two Different Protocols of Methotrexate Therapy in Medical Management of Ectopic Pregnancy
title_short Comparison of Two Different Protocols of Methotrexate Therapy in Medical Management of Ectopic Pregnancy
title_sort comparison of two different protocols of methotrexate therapy in medical management of ectopic pregnancy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706730/
https://www.ncbi.nlm.nih.gov/pubmed/26756008
http://dx.doi.org/10.5812/ircmj.20147
work_keys_str_mv AT saadatinajmieh comparisonoftwodifferentprotocolsofmethotrexatetherapyinmedicalmanagementofectopicpregnancy
AT najafianmahin comparisonoftwodifferentprotocolsofmethotrexatetherapyinmedicalmanagementofectopicpregnancy
AT masihisara comparisonoftwodifferentprotocolsofmethotrexatetherapyinmedicalmanagementofectopicpregnancy
AT safiarysara comparisonoftwodifferentprotocolsofmethotrexatetherapyinmedicalmanagementofectopicpregnancy
AT abediparvin comparisonoftwodifferentprotocolsofmethotrexatetherapyinmedicalmanagementofectopicpregnancy